Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Receivables - Other: 2018-2021

Historic Receivables - Other for Avadel Pharmaceuticals (AVDL) over the last 2 years, with Dec 2021 value amounting to $1.1 million.

  • Avadel Pharmaceuticals' Receivables - Other fell 23.25% to $1.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year decrease of 23.25%. This contributed to the annual value of $1.1 million for FY2021, which is 23.25% down from last year.
  • As of Q4 2021, Avadel Pharmaceuticals' Receivables - Other stood at $1.1 million, which was down 23.25% from $1.4 million recorded in Q4 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Receivables - Other peaked at $6.5 million during Q2 2018, and registered a low of $1.1 million during Q4 2021.
  • For the 3-year period, Avadel Pharmaceuticals' Receivables - Other averaged around $3.4 million, with its median value being $1.8 million (2019).
  • Data for Avadel Pharmaceuticals' Receivables - Other shows a maximum YoY tumbled of 73.76% (in 2020) over the last 5 years.
  • Over the past 4 years, Avadel Pharmaceuticals' Receivables - Other (Quarterly) stood at $6.2 million in 2018, then tumbled by 70.78% to $1.8 million in 2019, then fell by 24.88% to $1.4 million in 2020, then declined by 23.25% to $1.1 million in 2021.
  • Its Receivables - Other stands at $1.1 million for Q4 2021, versus $1.4 million for Q4 2020 and $1.6 million for Q2 2020.